Viewing StudyNCT00179751



Ignite Creation Date: 2024-05-05 @ 11:55 AM
Last Modification Date: 2024-10-26 @ 9:16 AM
Study NCT ID: NCT00179751
Status: TERMINATED
Last Update Posted: 2005-11-07
First Post: 2005-09-10

Brief Title: A Phase III Study of Lenalidomide in Combination With Gemcitabine in Patients With Untreated Advanced Carcinoma of the Pancreas
Sponsor: Celgene Corporation
Organization: Celgene

Conditions & Keywords Data

Conditions:
Name
Pancreatic Cancer
Keywords:
Name View
pancreatic cancer View
cc-5013 View
revlimid View